dactinomycin has been researched along with Adenoma, Islet Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchanan, KD; Cantwell, B; Collins, PG; Fennelly, JJ; Fielding, JF; FitzGerald, O | 1 |
| Cubilla, AL; Hajdu, SI | 1 |
| Missotten, M; Philippe, J | 1 |
3 other study(ies) available for dactinomycin and Adenoma, Islet Cell
| Article | Year |
|---|---|
Metastatic pancreatic vipoma: a case report of clinical response following treatment with corticosteroids and actinomycin D.
Topics: Adenoma, Islet Cell; Dactinomycin; Female; Humans; Indomethacin; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Prednisolone; Vasoactive Intestinal Peptide; Vipoma | 1982 |
Islet cell carcinoma of the pancreas.
Topics: Adenoma, Islet Cell; Adolescent; Adult; Aged; Child; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Hyperglycemia; Hypoglycemia; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Pancreas; Pancreatic Neoplasms; Streptozocin | 1975 |
Dexamethasone inhibits insulin biosynthesis by destabilizing insulin messenger ribonucleic acid in hamster insulinoma cells.
Topics: Adenoma, Islet Cell; Animals; Cricetinae; Cycloheximide; Dactinomycin; Dexamethasone; Dose-Response Relationship, Drug; Gene Expression; Half-Life; Insulin; Insulinoma; Mifepristone; Receptors, Glucocorticoid; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1990 |